Moleculin Biotech, Inc. - 8-K Filing

Moleculin Biotech posted an updated investor presentation on its website for a corporate update. (Items: 7.01 of this Current Report on Form 8-K, including Exhibit 99)

SEC EDGAR ·

Tickers: $MBRX

Read the full article at SEC EDGAR

More Regulatory news